Further, these studies support the concept that MYC-based mouse models of prostate cancer are useful “reagent mice” for studying the genetic, epigenetic, and microenvironmental changes that cooperate with MYC and lead to advanced and metastatic disease. The gene discussed is MYC; the disease is prostate carcinoma.